ICU Medical, Inc. (NASDAQ:ICUI) Position Trimmed by KBC Group NV

KBC Group NV cut its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 93.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,131 shares of the medical instruments supplier's stock after selling 16,172 shares during the period. KBC Group NV's holdings in ICU Medical were worth $157,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of ICUI. Harvest Fund Management Co. Ltd acquired a new position in ICU Medical during the fourth quarter valued at approximately $33,000. Quarry LP lifted its position in ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after buying an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp acquired a new position in ICU Medical during the fourth quarter valued at approximately $52,000. Russell Investments Group Ltd. lifted its position in ICU Medical by 88.8% during the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after buying an additional 300 shares in the last quarter. Finally, Sterling Capital Management LLC lifted its position in ICU Medical by 813.5% during the fourth quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock valued at $105,000 after buying an additional 602 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Stock Up 2.2%

Shares of NASDAQ:ICUI traded up $2.83 during midday trading on Tuesday, reaching $132.54. The company had a trading volume of 184,139 shares, compared to its average volume of 259,719. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.59 and a quick ratio of 1.52. The stock's fifty day moving average price is $134.00 and its 200-day moving average price is $145.44. The stock has a market capitalization of $3.26 billion, a P/E ratio of -34.61 and a beta of 0.87. ICU Medical, Inc. has a one year low of $117.92 and a one year high of $196.26.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.23 by $0.49. The business had revenue of $599.49 million during the quarter, compared to analyst estimates of $574.15 million. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The business's revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.96 earnings per share. Equities research analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Insider Activity at ICU Medical

In related news, Director Elisha W. Finney sold 600 shares of ICU Medical stock in a transaction on Monday, May 19th. The shares were sold at an average price of $138.92, for a total value of $83,352.00. Following the completion of the sale, the director owned 3,252 shares in the company, valued at approximately $451,767.84. The trade was a 15.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ben Sousa sold 2,000 shares of the business's stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $137.36, for a total transaction of $274,720.00. Following the sale, the insider owned 479 shares of the company's stock, valued at approximately $65,795.44. The trade was a 80.68% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 36,097 shares of company stock worth $4,860,156 in the last ninety days. 1.50% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Sunday, May 18th. KeyCorp dropped their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Raymond James Financial dropped their price objective on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a research note on Friday, May 9th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $192.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.